- The guidelines have been published in the Multiple Sclerosis and Related Disorders (MSARD) medical journal.
- The guidelines ensure that treatment plans are more effective, ensuring that patients receive early treatment with the most appropriate medication.
- They can facilitate early initiation of emerging treatments and ensure that insurance coverage follows an evidence-based treatment sequence driven by data rather than costs.